Patients can:
• Register and sign-on through the Patient Dapp interface,
• Upload their health records in the Blockchain, • Visualize their patient record,
• Authorize the sharing of their identified patient record to providers,
• Expose and sell their health records in the Marketplace against RWE tokens,
• Visualize a full audit-trail on their patient record access and health records sold,
• Visualize a statement of his/her RWE transactions.
Providers can:
• Register and sign-on through the Provider Dapp interface,
• Visualize an identified patient record, with due consent from the patient,
• Perform a health record quality check, when requested by the health record data owner,
• Visualize a statement of his/her RWE transactions,
Care Centers and other Data Owners can:
• Register and sign-on through the Data Owner Dapp interface,
• Have their health records indexed into the Blockchain and linked to patients,
• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,
• Visualize a statement of RWE transactions,
Pharma companies, Payers and other Data Buyers can:
• Register and sign-on through the Data Buyer Dapp interface,
• Expose their inclusion criteria for health record purchases,
• Browse a list of data owners which own health records matching their inclusion criteria,
• Select the data owners they wish to purchase health records from,
• Execute the purchase in RWE tokens with data owners,
• Visualize a statement of RWE transactions,
Pharma companies and authorities can:
• Register and sign-on through the Real-World Evidence Dapp interface,
• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,
• Authorities can visualize the shared Real-World Evidence from Pharma companies.
We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.
